You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
張江高科(600895.SH):就掛牌轉讓上海奇都100%股權 與上海齊魯製藥研究中心簽署產權交易合同
格隆匯 01-29 15:03

格隆匯 1 月 29日丨張江高科(600895.SH)公佈,就以掛牌方式轉讓上海奇都科技發展有限公司100%股權,20201211日至202118期間,項目在上海聯合產權交易所有限公司進行公開掛牌,掛牌價格人民幣28966.35萬元。至掛牌期滿,上海齊魯製藥研究中心有限公司成為該項目唯一意向受讓方。上海齊魯製藥研究中心有限公司2021120簽署《上海市產權交易合同》並於2021127取得上海聯合產權交易所有限公司產權交易憑證》,最終交易價格人民幣28966.35萬元。

公司通過公開掛牌方式轉讓公司全資子公司上海奇都科技發展有限公司100%股權,有利於提升上市公司經營業績,滿足公司後續於張江科學城運營的資金需求。之後公司將與上海齊魯製藥研究中心有限公司履行工商變更手續,公司預計將實現税後利潤約1.7億元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account